Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02601378
Recruitment Status : Terminated (The combination part of the study was terminated early due to business reasons)
First Posted : November 10, 2015
Last Update Posted : June 14, 2022
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 7, 2022
Actual Study Completion Date : January 7, 2022